Viewing
|Articles|August 10, 2020

Efficacy and safety of intravitreal aflibercept (Eylea®) therapy using a proactive treat-and-extend regimen in neovascular AMD

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME